Recordati reported EUR423.85M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Almirall EUR 191.9M 185.49M Mar/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Orion EUR 248.3M 46.5M Jun/2025
Sanofi EUR 7.74B 26M Jun/2025